Quantitative study of ductal breast cancer progression. A progression index (P.I.) for premalignant lesions and in situ carcinoma

Pathology Research and Practice

Volumn 192, Issue 5, 1996, Pages 428-436

  Mariuzzi, Gian Mario ^a   Mariuzzi, L ^b   Mombello, A ^a   Santinelli, A ^c   Valli, M ^c   Rahal, D ^a   Thompson, D ^d   Bartels, P H ^d  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Atypical epitheliosis; Breast; C erb B2; Ductal cancer; Ductal carcinoma in situ (DCIS); Epitheliosis; Grading; Prognosis; Progression index (P.I.); Quantitative pathology

Indexed keywords

ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; CELL NUCLEUS; HUMAN; HUMAN TISSUE; NUCLEOLUS; PRECANCER; PROGNOSIS; TUMOR GROWTH;

EID: 0030016267     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80004-5     Document Type: Article

References (25)

1. Bartkova J, Barnes DM, Millis RR, Gullick WJ (1990) Immunohistochemical demonstration of c-erb-B2 protein in mammary ductal carcinoma in situ. Hum Pathol 21: 1164-1167
2. Bodian CA, Perzin KH, Lattes R, Hoffmann P (1993) Reproducibility and validity of pathologic classification of benign breast disease and implication for clinical applications. Cancer 71: 3908-3913
3. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG (1993) Prognostic significance of benign proliferative breast disease. Cancer 71: 3896-3907
4. Henson DE, Ries L, Freedman LS, Carriaga M (1991) Relationship among outcome, stage of disease, and histologic grade for 22.616 cases of breast cancer. The basis for a prognostic index. Cancer 68: 2142-2149
5. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B (1994) Ductal carcinoma in situ: a proposal for a new classification. Seminars in Diagnostic Pathology 11: 167-180
6. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, DePalo AA, Rosen PP (1989) Breast carcinoma in situ. Arch Surg 124: 33-36
7. Mariuzzi GM, Mambelli V, Santinelli A, Mariuzzi L (1992) The microscopical classification of proliferative breast disease resulting from the muhiparametrical quantitative evaluation of genetic instability (suppl.). Cancer Detection Prevention 16: 81-86
8. Mariuzzi GM, Sisti S, Santinelli A, Valli M, Mariuzzi L (1992) Evolutionary somatic cell changes in cervical tumor progression quantitatively evaluated with morphological, histochemical and kinetic parameters. Pat Res Pract 188: 454-460
9. Mariuzzi GM, Sisti S (1993) Multivariate quantitative histopathological assessment of prognostic factors in ductal infiltrating breast carcinoma. In Vivo 7: 357-362
10. Mariuzzi GM, Mariuzzi L, Mombello A, Santinelli A, Valli M, Rahal D, Thompson D, Bartels PH (1994) Quantitative study of ductal breast cancer progression. Morphometric evaluation of phenotypical changes occurring in benign and preinvasive epithelial lesions. Pat Res Pract 190: 1056-1065
11. Mayr NA, Staples JJ, Robinson RA, Vanmetre JE, Hussey DH (1991) Morphometric studies in intraductal breast carcinoma using computerized image analysis. Cancer 67: 2805-2812
12. Neal HJ, Hurst PR (1992) The estimation of mean nuclear volume in the diagnosis of breast carcinoma. Diagn Cytopathol 8: 293-298
13. Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A longterm follow-up study. Cancer 55: 2698-2708
14. Page DL, Dupont WD (1990) Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66: 1326-1335
15. Page DL (1991) Prognosis and breast cancer. Recognition of lethal and favourable prognostic types. Am J Surg Pathol 15: 334-349
16. Page DL, Rogers LW (1992) Combined histologic and cytologic criteria for the dignosis of mammary atypical ductal hyperplasia. Hum Pathol 23: 1095-1097
17. Patchefsky AS, Schwartz GF, Finkelstein SD, Prestipino A, Sohn SE, Singer JS, Feig SA (1989) Heterogeneity of intraductal carcinoma of the breast. Cancer 63: 731-741
18. Rosai J (1991) Borderline epithelial lesions of the breast. Am J Surg Pathol 15: 209-221
19. Rosen PP (1993) Proliferative breast "disease". An unresolved diagnostic dilemma. Cancer 71: 3798-3806
20. Schimmelpenning H, Eriksson ET, Falkmer UG, Azavedo E, Svane G, Auer GU (1992) Expression of the c-erb-B2 protooncogene product and nuclear DNA content in benign and malignant human breast parenchyma. Virchows Archiv A (Pathol Anat) 420: 433-440
21. Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelmann R, Page DL (1992) Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 16: 1133-1143
22. Silvestrmi R (1991) Feasibility and reproducibility of the (3H)-thyrmdine labelling index in breast cancer. Cell Prol 24: 437-445
23. Simpson JF, Page DL (1994) Status of breast cancer prognostication based on histopathologic data (suppl. 1). Am J Clin Pathol 202: S3-S8
24. van Dongen JA, Holland R, Peterse JL, Fentiman IS, Lagios MD, Millis RR, Recht A (1992) Ductal carcinoma in-situ of the breast; second EORTC consensus meeting. Eur J Cancer 28: 626-629
25. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL (1988) Genetic alterations during colorectal tumor development. New Engl J Med 319: 525-532